Phase 1 Diabetic Retinopathy Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Diabetic RetinopathyDiabetic Macular EdemaMacular Edema+2 more
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.45 enrolled3 locationsNCT04187443
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Retinitis PigmentosaMacular DegenerationDiabetic Retinopathy+3 more
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled2 locationsNCT05147701
Recruiting
Phase 1
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Diabetic RetinopathyDiabetic Macular Edema
Therini Bio Pty Ltd21 enrolled2 locationsNCT06701721